查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
癌症生物製品市場，按類型、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1397151

癌症生物製品市場，按類型、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Cancer Biologics Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年癌症生物製品市場規模為 1,135.004 億美元，2023 年至 2030 年複合CAGR為 8.1%。

癌症生物製品市場-市場動態

癌症盛行率的上升和癌症生物技術的進步預計將推動癌症生物製品市場的成長

隨著癌症病例數量的持續增加，對更有效、更有針對性的癌症治療的需求也不斷增加。癌症生物製劑可以專門針對癌細胞或通路，為改善治療結果提供了一條有希望的途徑。根據國際癌症研究機構 GLOBOCAN 2020 估計，2020 年全球約有 1,930 萬新發癌症病例（不包括非黑色素瘤皮膚癌），近 1,000 萬人因癌症死亡（不包括非黑色素瘤皮膚癌）。僅各州， 2020 年就報告了1,603,844 例新癌症病例和602,347 例癌症相關死亡，每10 萬人報告了403 例新癌症病例和144 例癌症相關死亡。生物技術的進步促進了更精確和個人化治療方法的發展。生物技術的進步為更精確和個人化的治療方法鋪平了道路。此外，研發投資的增加推動了癌症生物製劑市場的成長機會。然而，生物製品的研究、開發和生產相關的高成本對市場成長構成了挑戰。

癌症生物製品市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球癌症生物製品市場在預測期內（2023-2030 年）每年將以 8.1% 左右的CAGR成長

根據類型細分，預計單株抗體將在 2022 年顯示最大的市場佔有率

根據應用細分，乳癌是 2022 年的主導類型

根據最終用戶細分，醫院是 2022 年的領先類型

按地區分類，北美是 2022 年的主要收入來源

癌症生物製品市場-細分分析：

全球癌症生物製品市場根據類型、應用、最終用戶和地區進行細分。

市場依類型分為三類：單株抗體、疫苗、細胞和基因治療等。單株抗體是市場的主導力量，在各個領域發揮影響力。它們的應用範圍廣泛，包括癌症治療、自體免疫疾病的管理和傳染病的治療。當談到癌症時，單株抗體具有特異性靶向癌細胞中發現的蛋白質的能力。另一方面，在自體免疫疾病領域，它們可以有效調節免疫反應。

根據應用，市場分為兩類：非小細胞肺癌、攝護腺癌、乳癌、急性骨髓性白血病、淋巴瘤、多發性骨髓瘤、卵巢癌、大腸直腸癌、胃癌等。乳癌在市場上佔有重要佔有率。它屬於腫瘤學或癌症護理領域，而呼吸健康和診斷則包括肺部評估設備。

根據最終用戶，市場分為兩類：醫院、診所和其他。醫院產業在市場上佔有重要地位，其中肺部評估設備市場是重要組成部分。醫院是使用各種診斷和監測設備（包括肺部評估設備）的主要醫療保健提供者。

癌症生物製品市場 - 地理洞察

癌症生物製品市場涵蓋範圍廣泛，橫跨北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據對市場做出貢獻的國家進一步細分。由於其先進的醫療基礎設施，北美地區預計將引領市場成長。尤其是美國，人均醫療保健支出和占GDP的比重都很高，明顯高於其他高收入國家。然而，美國是唯一沒有全民健康覆蓋的國家。根據醫療保險和醫療補助服務中心的數據，2021 年，美國的國家醫療保健支出達到 4.3 兆美元，即人均 12,914 美元，預計到 2028 年將達到 6.2 兆美元。與大多數國家相比，美國的醫療保健系統也更加昂貴，2019 年醫療保健支出佔 GDP 的近 16.8%。相比之下，德國的支出為 11.7%，瑞士的支出為 11.3%。在標靶治療的擴展和免疫療法的進步的推動下，歐洲是第二大癌症生物製品市場。

癌症生物製品市場-競爭格局：

癌症生物製品市場涵蓋多種產品，例如單株抗體、重組治療蛋白、疫苗、血液和血液成分、細胞療法和基因療法。由於重組 DNA 技術的進步，生物製劑在製藥業中變得非常重要，使得單株抗體和融合蛋白等產品的大規模生產成為可能。此外，分析技術得到了改進，促進了生物製劑的更好表徵以及具有複雜結構和治療功能的新型生物製劑的發現。此外，高技能生物技術專業人員回流中國縮小了跨國公司與本土競爭對手之間的技術差距。公司通常會組成策略聯盟，以增強其能力、擴大其產品組合或進入新市場。癌症生物製劑市場的競爭分析涉及評估該領域公司的動態、策略和定位。擁有處於不同發展階段的強大癌症生物製劑產品線的公司可能在未來的市場佔有率方面擁有競爭優勢。

最近的發展：

2021 年 7 月 27 日 - 安進 (Amgen) 和 Teneobio 今天宣布，安進 (Amgen) 將收購 Teneobio，這是一家私營臨床階段生物技術公司，研究一類名為人類重鏈抗體的新型生物製劑。

目錄

第 1 章：癌症生物製品市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的癌症生物製品市場片段
    • 癌症生物製品市場片段（按應用）
    • 最終用戶的癌症生物製品市場片段
    • 按國家/地區分類的癌症生物製品市場摘要
    • 按地區分類的癌症生物製品市場片段
  • 競爭洞察

第 3 章：癌症生物製品主要市場趨勢

  • 癌症生物製品市場促進因素
    • 市場促進因素的影響分析
  • 癌症生物製品市場限制
    • 市場限制影響分析
  • 癌症生物製品市場機會
  • 癌症生物製品市場未來趨勢

第 4 章：癌症生物製品產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：癌症生物製品市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：癌症生物製品市場格局

  • 2022 年癌症生物製品市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：癌症生物製品市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 單株抗體
    • 疫苗
    • 細胞和基因治療
    • 其他

第 8 章：癌症生物製劑市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 非小細胞肺癌
    • 攝護腺癌
    • 乳癌
    • 急性骨髓性白血病
    • 淋巴瘤
    • 多發骨髓瘤
    • 卵巢癌
    • 大腸直腸癌
    • 胃癌
    • 其他

第 9 章：癌症生物製品市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章：癌症生物製品市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美癌症生物製品主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲癌症生物製品主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區癌症生物製劑主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲癌症生物製品主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲癌症生物製品主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 癌症生物製品產業

  • 競爭儀表板
  • 公司簡介
    • Merck & Co., Inc.
    • Novartis International AG
    • F. Hoffmann-La Roche AG
    • Eli Lilly and Company
    • Bristol-Myers Squibb Company
    • Amgen Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Bayer AG
    • EnGeneIC Ltd
    • GlaxoSmithKline PLC. XX
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1922

REPORT HIGHLIGHT

Cancer Biologics Market size was valued at USD 113,500.4 Million in 2022, expanding at a CAGR of 8.1% from 2023 to 2030.

Biological therapy, a form of cancer treatment, harnesses the body's immune system to eliminate cancer cells. This approach has the potential to impede or decelerate tumor growth and halt the spread of cancer. In conjunction with surgery, chemotherapy, or radiation therapy, cancer biologics are frequently employed. The utilization and advancement of cancer biologics signify a significant breakthrough in the realm of oncology, offering more precise and less harmful treatment alternatives for certain cancer types. Moreover, through contemporary laboratory techniques, scientists can generate substantial quantities of Biological Response Modifiers (BRMs) for the treatment of cancer and other ailments like rheumatoid arthritis and Crohn's disease. Unlike conventional chemotherapy, which employs chemical compounds to eradicate rapidly dividing cells, cancer biologics aim to disrupt specific pathways or molecules associated with cancer progression.

Cancer Biologics Market- Market Dynamics

Rise in prevalence of cancer and advancements in cancer biotechnology are expected to drive the growth of cancer Biologics Market

The demand for more effective and targeted cancer treatments is increasing as the number of cancer cases continues to rise. Cancer biologics, which can specifically target cancer cells or pathways, offer a promising avenue for improving therapeutic outcomes. According to the International Agency for Research on Cancer's GLOBOCAN 2020 estimates, there were approximately 19.3 million new cancer cases (excluding non-melanoma skin cancer) and nearly 10.0 million cancer deaths (excluding non-melanoma skin cancer) worldwide in 2020. In the United States alone, there were 1,603,844 new cancer cases reported and 602,347 cancer-related deaths in 2020, with a reported rate of 403 new cancer cases and 144 cancer-related deaths per 100,000 people. Advances in biotechnology have led to the development of more precise and personalized treatment approaches. The advancements in biotechnology have paved the way for more precise and personalized treatment approaches. Moreover, the growth opportunity of the cancer biologics market is fueled by increasing investments in research and development. However, the high costs associated with the research, development, and production of biologics pose a challenge to market growth.

Cancer Biologics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Cancer Biologics market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2023-2030)
  • Based on Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2022
  • Based on application segmentation, Breast cancer was the leading type in 2022
  • Based on End-User segmentation, hospitals were the leading type in 2022
  • based on region, North America was the leading revenue generator in 2022

Cancer Biologics Market- Segmentation Analysis:

The Global Cancer Biologics Market is segmented based on Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, and Others. Monoclonal antibodies are the leading force in the market, exerting their influence across various fields. Their applications span a wide spectrum, encompassing cancer treatment, management of autoimmune diseases, and therapy for infectious diseases. When it comes to cancer, mAbs possess the ability to specifically target proteins found in cancer cells. On the other hand, in the realm of autoimmune diseases, they can effectively regulate the immune response.

The market is divided into two categories based on application: Non-Small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, and Others. Breast cancer holds a significant share in the market. It belongs to the field of oncology or cancer care, whereas respiratory health and diagnostics encompass lung assessment devices.

The market is divided into two categories based on End-User: Hospitals, Clinics, and Others. The hospital industry holds a strong position in the market, with the Lung Assessment Devices market being a crucial component. Hospitals are the primary healthcare providers that use a variety of diagnostic and monitoring devices, including lung assessment devices.

Cancer Biologics Market- Geographical Insights

The Cancer Biologics Market has a wide geographical reach, spanning across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented based on the countries that contribute to the market. The North American region is expected to lead the market growth, owing to its advanced healthcare infrastructure. The United States, in particular, has a high healthcare spending per person and a share of GDP, which is significantly higher than other high-income countries. However, the US is the only country without universal health coverage. In 2021, the national healthcare expenditure in the US reached USD 4.3 trillion, or USD 12,914 per person, and is projected to reach USD 6.2 trillion by 2028, according to the Centers for Medicare and Medicaid Services. The US healthcare system is also more expensive compared to most countries, with nearly 16.8% of GDP spent on healthcare in 2019. In contrast, Germany spent 11.7% and Switzerland spent 11.3%. Europe is the second-largest Cancer Biologics Market, driven by the expansion of targeted therapies and advancements in immunotherapies.

Cancer Biologics Market- Competitive Landscape:

The cancer biologics market encompasses a diverse array of products, such as monoclonal antibodies, recombinant therapeutic proteins, vaccines, blood and blood components, cell therapy, and gene therapy. Biologics have gained significant importance in the pharmaceutical industry due to advancements in recombinant DNA technologies, enabling large-scale production of products like mAbs and fusion proteins. Furthermore, analytical technologies have improved, facilitating better characterization of biologics and the discovery of novel biologics with intricate structures and therapeutic functions. Moreover, the return of highly skilled biotech professionals to China has bridged the technological gap between multinational companies and local competitors. Strategic alliances are often formed by companies to enhance their capabilities, expand their product portfolios, or enter new markets. Competitive analysis of the cancer biologics market involves evaluating the dynamics, strategies, and positioning of companies operating in this sector. Companies with a robust pipeline of cancer biologics at various stages of development may possess a competitive edge in terms of future market presence.

Recent Developments:

July 27, 2021 - Amgen and Teneobio announced today that Amgen would purchase Teneobio, a privately owned clinical-stage biotechnology business researching a novel class of biologics known as Human Heavy-Chain Antibodies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER BIOLOGICS MARKET KEY PLAYERS

  • Merck & Co., Inc.
  • Novartis International AG
  • F. Hoffmann-La Roche AG
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Amgen Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Bayer AG
  • EnGeneIC Ltd
  • GlaxoSmithKline PLC. XX
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY TYPE

  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY APPLICATION

  • Non-Small Cell Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Ovarian Cancer
  • Colorectal Cancer
  • Gastric Cancers
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Others

GLOBAL CANCER BIOLOGICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Biologics Market Snippet by Type
    • 2.1.2. Cancer Biologics Market Snippet by Application
    • 2.1.3. Cancer Biologics Market Snippet by End-User
    • 2.1.4. Cancer Biologics Market Snippet by Country
    • 2.1.5. Cancer Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Biologics Key Market Trends

  • 3.1. Cancer Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Biologics Market Opportunities
  • 3.4. Cancer Biologics Market Future Trends

4. Cancer Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Biologics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cancer Biologics Market Landscape

  • 6.1. Cancer Biologics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Biologics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Vaccines
    • 7.1.4. Cell and Gene Therapy
    • 7.1.5. Others

8. Cancer Biologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Non-Small Cell Lung Cancer
    • 8.1.3. Prostate Cancer
    • 8.1.4. Breast Cancer
    • 8.1.5. Acute Myeloid Leukemia
    • 8.1.6. Lymphoma
    • 8.1.7. Multiple Myeloma
    • 8.1.8. Ovarian Cancer
    • 8.1.9. Colorectal Cancer
    • 8.1.10. Gastric Cancers
    • 8.1.11. Others

9. Cancer Biologics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Cancer Biologics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cancer Biologics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cancer Biologics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cancer Biologics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cancer Biologics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cancer Biologics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Cancer Biologics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Merck & Co., Inc.
    • 11.2.2. Novartis International AG
    • 11.2.3. F. Hoffmann-La Roche AG
    • 11.2.4. Eli Lilly and Company
    • 11.2.5. Bristol-Myers Squibb Company
    • 11.2.6. Amgen Inc.
    • 11.2.7. Pfizer Inc.
    • 11.2.8. Sanofi S.A.
    • 11.2.9. Bayer AG
    • 11.2.10. EnGeneIC Ltd
    • 11.2.11. GlaxoSmithKline PLC. XX
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cancer Biologics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Cancer Biologics Market, by Type 2018-2030 (USD Million)
  • TABLE Cancer Biologics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cancer Biologics Market, by Application 2018-2030 (USD Million)
  • TABLE Cancer Biologics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cancer Biologics Market, by End-User 2018-2030 (USD Million)
  • TABLE Cancer Biologics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cancer Biologics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Cancer Biologics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Cancer Biologics Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Cancer Biologics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Cancer Biologics Market share and leading players, 2022
  • FIGURE Europe Cancer Biologics Market share and leading players, 2022
  • FIGURE Asia Pacific Cancer Biologics Market share and leading players, 2022
  • FIGURE Latin America Cancer Biologics Market share and leading players, 2022
  • FIGURE Middle East and Africa Cancer Biologics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Cancer Biologics Market share analysis by country, 2022
  • FIGURE Germany Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Cancer Biologics Market share analysis by country, 2022
  • FIGURE India Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Cancer Biologics Market share analysis by country, 2022
  • FIGURE Brazil Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Cancer Biologics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Cancer Biologics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)